Buclizine-dihydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁
Buclizine-dihydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁
Buclizine-dihydrochloride-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEBuclizine dihydrochlorideCat. No.: HY-A0128ACAS No.: 129-74-8分式: CHClN分量: 505.95作靶點(diǎn): Histamine Receptor作通路: GPCR/G Protein; Immunology/Inflammation; NeuronalSignaling儲存式: 4C, sealed storage, away from moisture* In solvent : -80C

2、, 6 months; -20C, 1 month (sealedstorage, away from moisture)溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 2.5 mg/mL (4.94 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 1.9765 mL 9.8824 mL 19.7648 mL5 mM - - -10 mM - - -請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Buclizine dihydro

3、chloride具有服活性的抗組胺、抗過敏化合物。Buclizine dihydrochloride 對種強(qiáng)效的致畸劑。體外研究Buclizine (0-100 M, 72 h) inhibits cancer cell growth by binding to TCTP and induction of cell differentiation3.Cell Proliferation Assay 3.1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemECell Line: MCF-7 cells 3.Concentration: 0-100 M.

4、Incubation Time: 72 h.Result: The IC50 was 19.18 5.32 M.體內(nèi)研究 Buclizine dihydrochloride (40 mg/kg) exhibits teratogenic effect 1.Buclizine dihydrochloride exhibits the t1/2 of 10 h via oral administration 2.Animal Model: Eighty-seven mature female rats weighing 24020 grams 1.Dosage: 30-200 mg/kg.Admi

5、nistration: From days 10 to 15.Result: Exhibits teratogenic effect dose-dependently when 40 mg/kg.REFERENCES1. C T King, et al. Teratogenic effect of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse. Am J Obstet Gynecol. 1966May 1;95(1):109-11.2. Nawab Sher, et al. Simultaneous d

6、etermination of antihistamine anti-allergic drugs, cetirizine, domperidone, chlorphenamine maleate,loratadine, meclizine and buclizine in pharmaceutical formulations, human serum and pharmacokinetics application. Analytical methods March 2014.3. Ean-Jeong Seo, et al. Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approachfor differentiation therapy. Oncotarget . 2016 Mar 29;7(13):16818-39.McePdfHeightCaution: Product has not been fully validated for medical applications.For research use only

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論